American Society of Hirudotherapy

Microvascular replantation of scalp and facial parts

Case series published in Surgical Technology International (1995)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Research reportClinical LiteratureKind GM et al. · Surgical technology international, 1995

Abstract

Replantation of fingers, hands, feet, and extremities has become a relatively common procedure. There are a number of reports of successful replants of facial parts. Since the feeding vessels are extremely small, these replants are most challenging. Venous outflow is the most common problem, and leeches and anticoagulants are commonly needed, resulting in considerable blood loss and transfusions. Nonetheless, the successful replantation of a facial part yields an aesthetic and functional result far superior to any other reconstructive option. We review our experience with 7 scalps, 4 ears, and 2 lips.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Summary

This review reports a series of 7 scalp, 4 ear, and 2 lip microvascular replants, in which venous outflow was the most common problem, commonly requiring leech therapy and anticoagulation with resulting significant blood loss and transfusion needs.

Why This Matters for Hirudotherapy

This article reviews the authors' experience with replantation of 7 scalps, 4 ears, and 2 lips, noting that venous outflow is the most common problem because the feeding vessels are extremely small. The abstract states that 'leeches and anticoagulants are commonly needed, resulting in considerable blood loss and transfusions' together as part of the management of these challenging cases. This is relevant to hirudotherapy because the abstract explicitly identifies leeches as a commonly used adjunct in facial and scalp replantation. However, the note cannot attribute the blood loss and transfusion burden to leeches alone, as the abstract assigns this to both leeches and anticoagulants combined, and no specific leech therapy protocols, outcomes, or comparative data are provided.

Citation

Reference (Vancouver style)

Kind GM, Buncke HJ, Muncke GM, Schreiber JS, Siko P, Venter TH. Microvascular replantation of scalp and facial parts. Surg Technol Int. 1995;IV:400-408. PMID: 21400465

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 27, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.